Where Will Moderna Be in 10 Years?
Ten years ago, Moderna (NASDAQ: MRNA) was a brand-new biotech still more than five years from advancing its first candidate into clinical testing. It was also eight years away from conducting the biggest initial public offering in biotech history.
Much has changed over the last decade. Moderna now claims a market cap of close to $30 billion. It's a pioneer in using messenger RNA (mRNA) to treat and prevent diseases. Moderna's mRNA-1273 ranks among the leaders in the coronavirus vaccine race.
Where will Moderna be 10 years from now? There's no way to know for sure, but here's one realistic possibility.
Source Fool.com
